Report cover image

Microfluidics Market Size, Share & Trends Analysis Report By Product (Microfluidic-based Devices, Microfluidic Components), By Application (Medical, Non-Medical), By Material (Silicon, Glass), By Technology, By Region, And Segment Forecasts, 2026 - 2033

Publisher Grand View Research
Published Dec 29, 2025
Length 120 Pages
SKU # GV20723945

Description

Microfluidics Market Summary

The global microfluidics market size was estimated at USD 41.92 billion in 2025 and is projected to reach USD 105.13 billion by 2033, growing at a CAGR of 12.22% from 2026 to 2033. This growth is primarily driven by the increasing adoption of microfluidic devices across various fields of research and diagnostics.

Advancements and Adoption of Microfluidics in Diagnostic Healthcare

The demand for reliable diagnostic tools is increasing due to the soaring hospital charges and frequent patient readmissions, while prehospital and point-of-care (POC) solutions, including at-home monitoring, are minimizing hospital visits and inpatient stays. Major players such as Abbott, Roche, and Danaher are pushing the growth of the IVD market by incorporating microfluidics into their diagnostic platforms for earlier disease detection, faster turnaround times, enhanced accuracy, and, at the same time, non-invasive sampling.

Microfluidics-enhanced PoCT solutions offer improved sensitivity, specificity, and faster turnaround times, prompting manufacturers to launch microfluidics-based diagnostic kits to address urgent testing needs. For example, in October 2021, LumiraDx received Emergency Use Authorization from India’s CDSCO for its COVID-19 antigen test, underscoring the critical role of microfluidics in pandemic response and public health diagnostics.

Global Microfluidics Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the microfluidics market report based on product, technology, material, application, and region.
  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Microfluidic-based Devices
  • Microfluidic Components
  • Chips
  • Micro-pumps
  • Sensors
  • Others
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Lab-on-a-chip
  • Organ-on-a-chip
  • Continuous Flow Microfluidics
  • Optofluidics & Microfluidics
  • Acoustofluidics & Microfluidics
  • Electrophoresis & Microfluidics
  • Material Outlook (Revenue, USD Million, 2021 - 2033)
  • Silicon
  • Glass
  • Polymer
  • PDMS
  • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Medical
  • Pharmaceuticals
  • Medical Devices
  • In-vitro Diagnostics
  • Others
  • Non-medical
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
Please note The report will be delivered in 2-3 business days upon order notification.

Table of Contents

120 Pages
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Product Segment
1.2.2. Application Segment
1.2.3. Material Segment
1.2.4. Technology Segment
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Advancements in 3D Printing & Digital Manufacturing
3.2.1.2. Rising Research & Development Investments
3.2.2. Market restraint analysis
3.2.2.1. High initial costs
3.3. Microfluidics Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
Chapter 4. Microfluidics Market: Product Business Analysis
4.1. Product Segment Dashboard
4.2. Global Microfluidics Market Product Movement Analysis
4.3. Global Microfluidics Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
4.4. Microfluidic-based Devices
4.4.1. Global Microfluidic based Devices Market, 2021 - 2033 (USD Million)
4.4.2. Chips
4.4.2.1. Global Chips Market, 2021 - 2033 (USD Million)
4.4.3. Micro-pumps
4.4.3.1. Global Micro-pumps Market, 2021 - 2033 (USD Million)
4.4.4. Sensors
4.4.4.1. Global Sensors Market, 2021 - 2033 (USD Million)
4.4.5. Others
4.4.5.1. Global Others Market, 2021 - 2033 (USD Million)
4.5. Microfluidic Components
4.5.1. Global Microfluidic Components Market, 2021 - 2033 (USD Million)
Chapter 5. Microfluidics Market: Application Business Analysis
5.1. Application Segment Dashboard
5.2. Global Microfluidics Market Application Movement Analysis
5.3. Global Microfluidics Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
5.4. Medical
5.4.1. Pharmaceuticals
5.4.1.1. Global Pharmaceuticals Market, 2021 - 2033 (USD Million)
5.4.2. Medical Devices
5.4.2.1. Global Medical Devices Market, 2021 - 2033 (USD Million)
5.4.3. In-vitro Diagnostics
5.4.3.1. Global In-vitro Diagnostics Market, 2021 - 2033 (USD Million)
5.4.4. Others
5.4.4.1. Global Others Market, 2021 - 2033 (USD Million)
5.5. Non-Medical
5.5.1. Global Non-Medical Market, 2021 - 2033 (USD Million)
Chapter 6. Microfluidics Market: Material Business Analysis
6.1. Material Segment Dashboard
6.2. Global Microfluidics Market Material Movement Analysis
6.3. Global Microfluidics Market Size & Trend Analysis, by Material, 2021 to 2033 (USD Million)
6.4. Silicon
6.4.1. Global Silicon Market, 2021 - 2033 (USD Million)
6.5. Glass
6.5.1. Global Glass Market, 2021 - 2033 (USD Million)
6.6. Polymer
6.6.1. Global Polymer Market, 2021 - 2033 (USD Million)
6.7. Polydimethylsiloxane (PDMS)
6.7.1. Global Polydimethylsiloxane (PDMS) Market, 2021 - 2033 (USD Million)
6.8. Others
6.8.1. Global Others Market, 2021 - 2033 (USD Million)
Chapter 7. Microfluidics Market: Technology Business Analysis
7.1. Technology Segment Dashboard
7.2. Global Microfluidics Market Technology Movement Analysis
7.3. Global Microfluidics Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
7.4. Lab-on-a-chip
7.4.1. Global Lab-on-a-chip Market, 2021 - 2033 (USD Million)
7.5. Organs-on-chips
7.5.1. Global Organs-on-chips Market, 2021 - 2033 (USD Million)
7.6. Continuous flow microfluidics
7.6.1. Global Continuous Flow Microfluidics Market, 2021 - 2033 (USD Million)
7.7. Optofluidics and microfluidics
7.7.1. Global Optofluidics and microfluidics Market, 2021 - 2033 (USD Million)
7.8. Acoustofluidics and microfluidics
7.8.1. Global Acoustofluidics and microfluidics Market, 2021 - 2033 (USD Million)
7.9. Electrophoresis and microfluidics
7.9.1. Global Electrophoresis and microfluidics Market, 2021 - 2033 (USD Million)
Chapter 8. Regional Microfluidics Market: Region Estimates & Trend Analysis
8.1. North America
8.1.1. North America market estimates and forecasts 2021 - 2033 (USD Million)
8.1.2. U.S.
8.1.2.1. Key country dynamics
8.1.2.2. Competitive scenario
8.1.2.3. Regulatory Framework
8.1.2.4. U.S. market estimates and forecasts 2021 - 2033 (USD Million)
8.1.3. Canada
8.1.3.1. Key country dynamics
8.1.3.2. Competitive scenario
8.1.3.3. Regulatory Framework
8.1.3.4. Canada market estimates and forecasts 2021 - 2033 (USD Million)
8.1.4. Mexico
8.1.4.1. Key country dynamics
8.1.4.2. Competitive scenario
8.1.4.3. Regulatory Framework
8.1.4.4. Mexico market estimates and forecasts 2021 - 2033 (USD Million)
8.2. Europe
8.2.1. Europe market estimates and forecasts 2021 - 2033 (USD Million)
8.2.2. UK
8.2.2.1. Key country dynamics
8.2.2.2. Competitive scenario
8.2.2.3. Regulatory Framework
8.2.2.4. UK market estimates and forecasts 2021 - 2033 (USD Million)
8.2.3. Germany
8.2.3.1. Key country dynamics
8.2.3.2. Competitive scenario
8.2.3.3. Regulatory Framework
8.2.3.4. Germany market estimates and forecasts 2021 - 2033 (USD Million)
8.2.4. France
8.2.4.1. Key country dynamics
8.2.4.2. Competitive scenario
8.2.4.3. Regulatory Framework
8.2.4.4. France market estimates and forecasts 2021 - 2033 (USD Million)
8.2.5. Italy
8.2.5.1. Key country dynamics
8.2.5.2. Competitive scenario
8.2.5.3. Regulatory Framework
8.2.5.4. Italy market estimates and forecasts 2021 - 2033 (USD Million)
8.2.6. Spain
8.2.6.1. Key country dynamics
8.2.6.2. Competitive scenario
8.2.6.3. Regulatory Framework
8.2.6.4. Spain market estimates and forecasts 2021 - 2033 (USD Million)
8.2.7. Norway
8.2.7.1. Key country dynamics
8.2.7.2. Competitive scenario
8.2.7.3. Regulatory Framework
8.2.7.4. Norway market estimates and forecasts 2021 - 2033 (USD Million)
8.2.8. Sweden
8.2.8.1. Key country dynamics
8.2.8.2. Competitive scenario
8.2.8.3. Regulatory Framework
8.2.8.4. Sweden market estimates and forecasts 2021 - 2033 (USD Million)
8.2.9. Denmark
8.2.9.1. Key country dynamics
8.2.9.2. Competitive scenario
8.2.9.3. Regulatory Framework
8.2.9.4. Denmark market estimates and forecasts 2021 - 2033 (USD Million)
8.3. Asia Pacific
8.3.1. Asia Pacific market estimates and forecasts 2021 - 2033 (USD Million)
8.3.2. Japan
8.3.2.1. Key country dynamics
8.3.2.2. Competitive scenario
8.3.2.3. Regulatory Framework
8.3.2.4. Japan market estimates and forecasts 2021 - 2033 (USD Million)
8.3.3. China
8.3.3.1. Key country dynamics
8.3.3.2. Competitive scenario
8.3.3.3. Regulatory Framework
8.3.3.4. China market estimates and forecasts 2021 - 2033 (USD Million)
8.3.4. India
8.3.4.1. Key country dynamics
8.3.4.2. Competitive scenario
8.3.4.3. Regulatory Framework
8.3.4.4. India market estimates and forecasts 2021 - 2033 (USD Million)
8.3.5. Thailand
8.3.5.1. Key country dynamics
8.3.5.2. Competitive scenario
8.3.5.3. Regulatory Framework
8.3.5.4. Thailand market estimates and forecasts 2021 - 2033 (USD Million)
8.3.6. South Korea
8.3.6.1. Key country dynamics
8.3.6.2. Competitive scenario
8.3.6.3. Regulatory Framework
8.3.6.4. South Korea market estimates and forecasts 2021 - 2033 (USD Million)
8.3.7. Australia
8.3.7.1. Key country dynamics
8.3.7.2. Competitive scenario
8.3.7.3. Regulatory Framework
8.3.7.4. Australia market estimates and forecasts 2021 - 2033 (USD Million)
8.4. Latin America
8.4.1. Latin America market estimates and forecasts 2021 - 2033 (USD Million)
8.4.2. Brazil
8.4.2.1. Key country dynamics
8.4.2.2. Competitive scenario
8.4.2.3. Regulatory Framework
8.4.2.4. Brazil market estimates and forecasts 2021 - 2033 (USD Million)
8.4.3. Argentina
8.4.3.1. Key country dynamics
8.4.3.2. Competitive scenario
8.4.3.3. Regulatory Framework
8.4.3.4. Argentina market estimates and forecasts 2021 - 2033 (USD Million)
8.5. Middle East & Africa
8.5.1. Middle East & Africa market estimates and forecasts 2021 - 2033 (USD Million)
8.5.2. South Africa
8.5.2.1. Key country dynamics
8.5.2.2. Competitive scenario
8.5.2.3. Regulatory Framework
8.5.2.4. South Africa market estimates and forecasts 2021 - 2033 (USD Million)
8.5.3. Saudi Arabia
8.5.3.1. Key country dynamics
8.5.3.2. Competitive scenario
8.5.3.3. Regulatory Framework
8.5.3.4. Saudi Arabia market estimates and forecasts 2021 - 2033 (USD Million)
8.5.4. UAE
8.5.4.1. Key country dynamics
8.5.4.2. Competitive scenario
8.5.4.3. Regulatory Framework
8.5.4.4. UAE market estimates and forecasts 2021 - 2033 (USD Million)
8.5.5. Kuwait
8.5.5.1. Key country dynamics
8.5.5.2. Competitive scenario
8.5.5.3. Regulatory Framework
8.5.5.4. Kuwait market estimates and forecasts 2021 - 2033 (USD Million)
Chapter 9. Competitive Landscape
9.1. Company Categorization
9.2. Strategy Mapping
9.3. Company Market Position Analysis, 2025
9.4. Company Profiles/Listing
9.4.1. Illumina, Inc.
9.4.1.1. Overview
9.4.1.2. Financial Performance
9.4.1.3. Product Benchmarking
9.4.1.4. Strategic Initiatives
9.4.2. F. Hoffmann-La Roche Ltd.
9.4.2.1. Overview
9.4.2.2. Financial Performance
9.4.2.3. Product Benchmarking
9.4.2.4. Strategic Initiatives
9.4.3. Revvity
9.4.3.1. Overview
9.4.3.2. Financial Performance
9.4.3.3. Product Benchmarking
9.4.3.4. Strategic Initiatives
9.4.4. Agilent Technologies, Inc.
9.4.4.1. Overview
9.4.4.2. Financial Performance
9.4.4.3. Product Benchmarking
9.4.4.4. Strategic Initiatives
9.4.5. Danaher
9.4.5.1. Overview
9.4.5.2. Financial Performance
9.4.5.3. Product Benchmarking
9.4.5.4. Strategic Initiatives
9.4.6. Bio-Rad Laboratories, Inc.
9.4.6.1. Overview
9.4.6.2. Financial Performance
9.4.6.3. Product Benchmarking
9.4.6.4. Strategic Initiatives
9.4.7. thinXXS Microtechnology GmbH
9.4.7.1. Overview
9.4.7.2. Financial Performance
9.4.7.3. Product Benchmarking
9.4.7.4. Strategic Initiatives
9.4.8. Abbott
9.4.8.1. Overview
9.4.8.2. Financial Performance
9.4.8.3. Product Benchmarking
9.4.8.4. Strategic Initiatives
9.4.9. Thermo Fisher Scientific, Inc.
9.4.9.1. Overview
9.4.9.2. Financial Performance
9.4.9.3. Product Benchmarking
9.4.9.4. Strategic Initiatives
9.4.10. Standard BioTools
9.4.10.1. Overview
9.4.10.2. Financial Performance
9.4.10.3. Product Benchmarking
9.4.10.4. Strategic Initiatives

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us